AzTrials
AzTrials

DepressionNCT04055155

Technology-enabled Task-sharing for Depression in Primary Care

An observational study of Depression and Depression in Old Age, run by University of Washington at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study will explore and test the feasibility, acceptability, usability, and preliminary effectiveness of a technology-enabled intervention for depression using task-sharing in primary care. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Depression, Depression in Old Age
How many people
0 participants
Where
1 siteUnited States
Study dates
1 Sep 2019to 31 Aug 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Primary care clinics: administrators, primary care providers, behavioral health providers, frontline primary care staff (e.g., nurses, medical assistants) Patients: older adult primary care patients with mild-to-moderate depressive symptoms

Who may be able to join

  • Clinics:
  • have at least 1 full-time registered nurse (RN) and/or medical assistant (MA) on staff
  • include older adults on their patient panels.
  • Clinic administrators
  • have an administrative or leadership role in the clinic
  • have been employed in their current role for at least 6 months.
Show all 20Show fewer
  • Frontline staff
  • provide care as RN, MA, case manager, behavioral health consultant, or similar role identified by Practice Champion
  • be employed at the participating clinic for at least 6 months.
  • Patients
  • be ≥65 years of age
  • report moderate to moderately severe depressive symptoms based on a PHQ-9 score of 10-20
  • own or have access to a smartphone
  • have internet or cellular data plan
  • receive medical clearance from their primary care provider to participate in unstructured physical activity.
  • Patient exclusion criteria will be based on medical chart review by Practice Champion and include:
  • current suicidality
  • severe vision or hearing impairment
  • pronounced cognitive impairment
  • use of assistive devices that would impede physical activity.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Univeristy of Washington

    Seattle, Washington, 98195

Other trials in United States

About this study

Official title: Discovering the Capacity of Primary Care Frontline Staff to Deliver a Low-Intensity Technology-Enhanced Intervention to Treat Geriatric Depression

This study will explore and test the feasibility, acceptability, usability, and preliminary effectiveness of a technology-enabled intervention for depression using task-sharing in primary care. We will a) discover barriers and facilitators to task-sharing by frontline primary care staff; b) design an implementation strategy to support task-sharing to deliver a technology-enabled intervention for depression; and c) conduct a small open-label usability trial of the technology-enabled intervention for depression.

Read the detailed description

Older adults with depression typically present to primary care rather than specialty mental health treatment and are often un- or undertreated, as the demand for mental health services is greater than the supply of trained providers. Technology is one method to improve access to care by making evidence-based psychosocial interventions (EBPIs) readily accessible. A second method comes from global mental health research, demonstrating that task-sharing can equip non-specialists to provide effective mental health care. This study combines these two approaches, exploring how technology-enhanced EBPI could be used by frontline primary care staff (e.g., nurses, medical assistants) to expand workforce capacity to deliver acceptable, sustainable, and effective treatment for depression. Specifically, we will use task-sharing to deliver a mobile Motivational Physical Activity Targeted Intervention (MPATI), which is based on behavioral activation for depression and uses wearable accelerometer technology to trigger personalized activity goal monitoring. This proposal uses the Discover, Design/Build, Test (DDBT) framework, which leverages user-centered design and implementation science to discover implementation barriers to using task-sharing to deliver MPATI in primary care, to design an implementation strategy to support MPATI delivery, and to conduct a pilot usability trial to test the implementation strategy with the most suitable frontline staff.

Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04055155
Study groupRoleWhat they receive
Staff/Provider end-usersTesting usability of a technology-enabled behavioral intervention for depression among provider end-users in primary care.
Patient participantsTesting acceptability, feasibility, and preliminary effectiveness of a technology-enabled behavioral intervention for depression among patients with depression in primary care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Usability (system usability scale)

    usability of MPATI intervention among provider end-users

    Measured: after 2 week usability trial

  2. Usability (qualitative interviews)

    usability of MPATI intervention among provider end-users

    Measured: after 2 week usability trial

Secondary outcomes (4)
  1. feasibility -- patient recruitment

    feasibility of MPATI intervention for geriatric depression in primary care

    Measured: end of pilot trial (2 weeks per patient)

  2. acceptability -- patient retention

    acceptability of MPATI intervention for geriatric depression in primary care

    Measured: end of pilot trial (2 weeks per patient)

  3. depressive symptoms (patient)

    Patient Health Questionnaire (PHQ-9) total scores to assess depressive symptoms (total score range 0-27; higher scores reflect greater depressive symptoms)

    Measured: pre-post 2 week pilot trial

  4. functioning (patient)

    Sheehan Disability Scale (SDS) total scores to assess functional impairment; total scores range from 0 (unimpaired) to 30 (highly impaired).

    Measured: pre-post 2 week pilot trial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2019
  2. Study start1 Sep 2019
  3. Primary completion1 Jul 2020
  4. Study completion31 Aug 2020

Why it stopped: Pandemic halt

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04055155
Sponsor's protocol ID
STUDY00006748
Other IDs
P50MH115837
Status last verified
May 2023
First submitted
9 Aug 2019
Last updated
10 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Depression and Depression in Old Age, run by University of Washington at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 20 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 10 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Usability (system usability scale) (time frame: after 2 week usability trial). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in